148 related articles for article (PubMed ID: 22198192)
1. An approach to finding indications and contraindications for nephrectomy in post-transplant renal graft lymphomas: PTLD.Int survey.
Gholipour-Shoiili A; Gholipour-Shoiili H; Taheri S
Hematol Oncol Stem Cell Ther; 2011; 4(4):167-72. PubMed ID: 22198192
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey.
Khedmat H; Taheri S
Ann Transplant; 2010; 15(3):80-6. PubMed ID: 20877272
[TBL] [Abstract][Full Text] [Related]
3. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow involvement by lymphoproliferative disorders after renal transplantation: PTLD. Int. Survey.
Izadi M; Fazel M; Saadat SH; Taheri S
J Cancer Res Ther; 2012; 8(1):62-7. PubMed ID: 22531516
[TBL] [Abstract][Full Text] [Related]
5. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
[TBL] [Abstract][Full Text] [Related]
6. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
Rouphael B; Lankireddy S; Lazaryan A; Kukla A; Ibrahim HN; Matas AJ; Issa N
Clin Transplant; 2016 Jan; 30(1):60-5. PubMed ID: 26497471
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota.
Wudhikarn K; Holman CJ; Linan M; Blaes AH; Dunitz JM; Hertz ME; Peterson BA
Clin Transplant; 2011; 25(5):705-13. PubMed ID: 21077949
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow involvement by lymphoproliferative disorders post liver transplantation: PTLD Int Survey.
Khedmat H; Taheri S
Acta Med Indones; 2012 Jul; 44(3):207-13. PubMed ID: 22983075
[TBL] [Abstract][Full Text] [Related]
10. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
11. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
Purighalla R; Shapiro R; Jordan ML; Scantlebury VP; Gritsch HA; Vivas C; Randhawa PS
Clin Transplant; 1997 Dec; 11(6):574-6. PubMed ID: 9408687
[TBL] [Abstract][Full Text] [Related]
12. Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation.
Kew CE; Lopez-Ben R; Smith JK; Robbin ML; Cook WJ; Gaston RS; Deierhoi MH; Julian BA
Transplantation; 2000 Mar; 69(5):809-14. PubMed ID: 10755531
[TBL] [Abstract][Full Text] [Related]
13. Very late onset lymphoproliferative disorders occurring over 10 years post-renal transplantation: PTLD.Int. Survey.
Khedmat H; Taheri S
Hematol Oncol Stem Cell Ther; 2011; 4(2):73-80. PubMed ID: 21727768
[TBL] [Abstract][Full Text] [Related]
14. Features, predictors and prognosis of lymphoproliferative disorders post-liver transplantation regarding disease presentation time: report from the PTLD.Int. survey.
Izadi M; Taheri S
Ann Transplant; 2011; 16(1):39-47. PubMed ID: 21436773
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival after post-transplant lymphoproliferative disease in children.
Nathanson S; Debray D; Delarue A; DeschĂȘnes G
Pediatr Nephrol; 2002 Aug; 17(8):668-72. PubMed ID: 12185479
[TBL] [Abstract][Full Text] [Related]
16. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
Raj R; Frost AE
J Heart Lung Transplant; 2005 Jun; 24(6):671-9. PubMed ID: 15949726
[TBL] [Abstract][Full Text] [Related]
17. CD20 antigen expression by lymphoproliferative disorders after kidney transplant is independently associated with a poor outcome: PTLD.Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2012 Aug; 10(4):325-31. PubMed ID: 22758374
[TBL] [Abstract][Full Text] [Related]
18. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
Leung E; Shenton BK; Green K; Jackson G; Gould FK; Yap C; Talbot D
Transpl Infect Dis; 2004 Dec; 6(4):156-64. PubMed ID: 15762933
[TBL] [Abstract][Full Text] [Related]
19. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.
Cherikh WS; Kauffman HM; McBride MA; Maghirang J; Swinnen LJ; Hanto DW
Transplantation; 2003 Nov; 76(9):1289-93. PubMed ID: 14627905
[TBL] [Abstract][Full Text] [Related]
20. Small intestinal involvement by lymphoproliferative disorders post-renal transplantation: a report from the post-transplant lymphoproliferative disorder international survey.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 May; 24(3):487-94. PubMed ID: 23640619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]